Detection and Treatment of Schizophrenia
a treatment method and schizophrenia technology, applied in the field of diagnosis of schizophrenia, can solve the problems of inability to determine the decisive treatment method, inability to analyze the candidate gene of various researchers, and inability to explain the pathological condition in terms of biochemistry, so as to achieve the effect of reducing the stress of carbonyl compounds, facilitating and objectively making, and improving the condition
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Benefits of technology
Problems solved by technology
Method used
Image
Examples
example 1
Genetic and Biochemical Analyses on Patient with Severe Schizophrenia
[0519] A schizophrenic patient (male, 60 years, weight 75.5 kg) hospitalized in a psychiatric hospital (hereinafter “Patient A”) underwent analysis of the glyoxalase I gene, as well as measurement of the erythrocyte glyoxalase activity, the serum AGE level, and the quantity of serum vitamin B6. Patient A is one of four siblings, two of whom committed suicide; he and the other remaining sibling are currently hospitalized in a psychiatric hospital. Patient A has been diagnosed with severe familial schizophrenia.
[0520] Measurement Methods
[0521] (1) Measurement of Erythrocyte Glyoxalase Activity
[0522] The erythrocyte glyoxalase activity was measured according to the method of McLellan et al. (McLellan A C, Thornalley P J: Glyoxalase activity in human red blood cells fractioned by age. Mech Ageing Dev 48: 63-71, 1989). Specifically, disrupted erythrocytes were added to a hemithioacetal solution produced from methylg...
example 2
Measurement of the AGE Content in the Skin
[0538] AGE contents in the skin were measured in healthy subjects (12 females and 12 males, a total of 24 subjects; average age: 48.88+3.17 years) and schizophrenic patients (12 females and 12 males, a total of 24 subjects; average age: 48.38+2.23 years), using an AGE Reader (manufactured by DiagnOptics, the Netherlands).
[0539]FIG. 7 shows a comparison of the AGE contents in the skin between the healthy subjects and schizophrenic patients. The results show that the AGE contents in the skin of the schizophrenic patients are significantly increased as compared to those of the healthy subjects. FIG. 8A and FIG. 8B show comparison of the AGE contents in the skin between the healthy subjects and schizophrenic patients according to age. The results revealed a strong positive correlation between the AGE content and age for the healthy subjects, but no such correlation was observed for the schizophrenic patients (FIG. 8A). However, as shown in FIG...
example 3
Analysis of Glyoxalase I Gene of Schizophrenic Patients
[0541] (1) Analysis of the glyoxalase I (GLO-I) gene was conducted on schizophrenic patients (n=700) and healthy subjects (n=600).
[0542] A frameshift mutation in the GLO-I gene (an insertion of a single base between positions 79 and 80 of the base sequence (SEQ ID NO: 1) of the coding region of the GLO-I gene) was identified by PCR-direct sequencing using Blend Taq (TOYOBO Cat#BTQ-101S), in which PCR was performed using PCR primers, F: 5′-GAGTTTGCCTCCTTTATGCG-3′ (SEQ ID NO: 8) and R: 5′-AACAGATCCCCTCCACACTT-3′ (SEQ ID NO: 9), under the conditions of (i) 1 cycle of 94° C. for 2 minutes; (ii) 40 cycles of 94° C. for 30 seconds, 62.5° C. for 20 seconds, 72° C. for 30 seconds; and (iii) 1 cycle of 72° C. for 2 minutes. A base substitution mutation (the mutation of alanine to cytosine at position 332 of the base sequence (SEQ ID NO: 1) of the coding region of the GLO-I gene), inducing the mutation of the amino acid (Glu→Ala) at pos...
PUM
| Property | Measurement | Unit |
|---|---|---|
| concentration | aaaaa | aaaaa |
| concentration | aaaaa | aaaaa |
| fluorescence wavelength | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
Login to View More